oxociprofloxacin has been researched along with ciprofloxacin in 5 studies
*Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline. [MeSH]
*Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline. [MeSH]
| Studies (oxociprofloxacin) | Trials (oxociprofloxacin) | Recent Studies (post-2010) (oxociprofloxacin) | Studies (ciprofloxacin) | Trials (ciprofloxacin) | Recent Studies (post-2010) (ciprofloxacin) |
|---|---|---|---|---|---|
| 5 | 1 | 0 | 16,060 | 1,331 | 6,092 |
| Protein | Taxonomy | oxociprofloxacin (IC50) | ciprofloxacin (IC50) |
|---|---|---|---|
| Gamma-aminobutyric acid receptor subunit pi | Rattus norvegicus (Norway rat) | 0.41 | |
| DNA gyrase subunit B | Bacillus subtilis subsp. subtilis str. 168 | 6.3 | |
| DNA gyrase subunit A | Bacillus subtilis subsp. subtilis str. 168 | 6.3 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.31 | |
| DNA gyrase subunit B | Staphylococcus aureus | 4.32 | |
| DNA gyrase subunit A | Escherichia coli K-12 | 0.6845 | |
| DNA gyrase subunit B | Escherichia coli K-12 | 0.5632 | |
| DNA topoisomerase 4 subunit B | Staphylococcus aureus | 6.485 | |
| DNA topoisomerase 4 subunit A | Staphylococcus aureus | 4.8011 | |
| Gamma-aminobutyric acid receptor subunit beta-1 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit delta | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit gamma-2 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit alpha-5 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit alpha-3 | Rattus norvegicus (Norway rat) | 0.41 | |
| DNA gyrase subunit A | Staphylococcus aureus | 4.32 | |
| Gamma-aminobutyric acid receptor subunit gamma-1 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit alpha-2 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit gamma-3 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit alpha-6 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit alpha-1 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit beta-3 | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit beta-2 | Rattus norvegicus (Norway rat) | 0.41 | |
| DNA topoisomerase 4 subunit A | Bacillus subtilis subsp. subtilis str. 168 | 1.7 | |
| DNA topoisomerase 4 subunit B | Bacillus subtilis subsp. subtilis str. 168 | 1.7 | |
| GABA theta subunit | Rattus norvegicus (Norway rat) | 0.41 | |
| Gamma-aminobutyric acid receptor subunit epsilon | Rattus norvegicus (Norway rat) | 0.41 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bacracheva, N; Chervenakov, P; Dobrev, P; Gerova, Z; Scholl, H; Vlahov, V | 1 |
| Bergan, T; Rohwedder, R; Scholl, H; Thorsteinsson, SB | 1 |
| Frost, RW; Krol, G; Lasseter, KC; Lettieri, JT; Shamblen, EC | 1 |
| Bren, A; Drinovec, J; Karba, R; Kozjek, F; Mrhar, A; Primozic, S; Varl, J | 1 |
| van der Meer, YG; van Geijlswijk, IM; van Zanten, AR | 1 |
1 trial(s) available for oxociprofloxacin and ciprofloxacin
| Article | Year |
|---|---|
The distribution of ciprofloxacin and its metabolites in human plasma, pulmonary and bronchial tissues.
Topics: Anti-Infective Agents; Bronchi; Ciprofloxacin; Female; Fluoroquinolones; Humans; Injections, Intravenous; Lung; Male; Middle Aged; Time Factors; Tissue Distribution | 1991 |
4 other study(ies) available for oxociprofloxacin and ciprofloxacin
| Article | Year |
|---|---|
Elimination of ciprofloxacin and three major metabolites and consequences of reduced renal function.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Female; Fluoroquinolones; Half-Life; Humans; Kidney Diseases; Male; Middle Aged; Time Factors | 1989 |
The effect of cirrhosis on the steady-state pharmacokinetics of oral ciprofloxacin.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Biotransformation; Chromatography, High Pressure Liquid; Ciprofloxacin; Fluoroquinolones; Half-Life; Humans; Liver Cirrhosis; Male; Middle Aged | 1989 |
Ciprofloxacin and oxociprofloxacin pharmacokinetics in patients on haemodialysis.
Topics: Adult; Aged; Anti-Infective Agents; Area Under Curve; Ciprofloxacin; Female; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis | 1989 |
Reliable new high-performance liquid chromatographic method for the determination of ciprofloxacin in human serum.
Topics: Animals; Cattle; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Monitoring; Drug Stability; Fluoroquinolones; Humans; Reproducibility of Results; Spectrophotometry, Ultraviolet; Temperature; Time Factors | 2006 |